The MAPRx Coalition appreciates the opportunity to provide the Centers for Medicare & Medicaid Services (CMS) with comments regarding Medicare Part D plan sponsor data reporting requirements, as requested in the notice published in the Federal Register on February 2, 2024.
Highlights include:
• Part D plan reporting on beneficiaries likely to benefit from... Read more
MAPRx urges Congress and CMS to establish comprehensive obesity coverage in Medicare Part D through a one pager.
Highlights include:
• Treat and Reduce Obesity Act: Bipartisan, bicameral legislation to establish anti-obesity medication coverage through Medicare Part D
• CMS Guidance: to establish AOM coverage thorough revised Part D plan guidance and/or regulation
Earlier today the MAPRx Coalition submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding the memorandum Medicare Prescription Payment Plan: Draft Part Two Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025, published on February 15, 2024.
MAPRx appreciates the opportunity to comment on... Read more
We are eager to hear about your experiences with the Medicare prescription drug program. We would like to hear about both good and bad experiences that you have had selecting and signing up for a plan, getting your drugs, and paying for your drugs. The form below will allow you to write your story.
Thank you for taking the time to tell us your story.